Biomarin Pharmaceutical (BMRN) Inventory Average (2010 - 2026)
Biomarin Pharmaceutical's (BMRN) quarterly Inventory Average came in at $1.3 billion in Q1 2026, up 2.58% YoY from $1.3 billion in Q1 2025, and down 4.06% on a QoQ basis from $1.3 billion in Q4 2025.
Biomarin Pharmaceutical (BMRN) Inventory Average (2010 - 2026) Analysis & Trends
Biomarin Pharmaceutical (BMRN) has 17 years of Inventory Average data on file, last reported at $1.3 billion in Q1 2026.
- Quarterly Inventory Average rose 2.58% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 2.58% YoY) and the FY2025 annual result came in at $1.3 billion, up 8.19% from the prior year.
- Inventory Average declined to $1.3 billion in Q1 2026, from $1.3 billion in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $1.4 billion in Q3 2025 to a low of $781.5 million in Q1 2022.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2024 — Inventory Average rose 23.84% — and 2026, when it gained 2.58%.
- Tracing BMRN's Inventory Average over 5 years: stood at $866.8 million in 2022, then advanced by 23.41% to $1.1 billion in 2023, then grew by 12.74% to $1.2 billion in 2024, then rose by 11.16% to $1.3 billion in 2025, then fell by 4.06% to $1.3 billion in 2026.
- The last three Inventory Average figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Biomarin Pharmaceutical | 13.04 Bn | 12.16 Bn | 786.91 Mn | 1.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Bn |
| Mar 31, 2026 | 1.29 Bn |
| Dec 31, 2025 | 1.34 Bn |
| Sep 30, 2025 | 1.36 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.12 Bn |
| Dec 31, 2023 | 1.07 Bn |
| Sep 30, 2023 | 1.00 Bn |
| Jun 30, 2023 | 947.23 Mn |
| Mar 31, 2023 | 906.50 Mn |
| Dec 31, 2022 | 866.77 Mn |
| Sep 30, 2022 | 820.89 Mn |
| Jun 30, 2022 | 794.34 Mn |
| Mar 31, 2022 | 781.51 Mn |
| Dec 31, 2021 | 763.04 Mn |
| Sep 30, 2021 | 730.19 Mn |